Dublin, Feb. 13, 2017 -- Research and Markets has announced the addition of the "Infusion Medication Management Systems" report to their offering.
Infusion is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug infusion have - according to several recent studies - contributed to medication errors and risks to patient safety.
The current generation of what can be referred to as infusion medication management systems are attempting to address the risks associated with infusion by incorporating electronic and programmable features that either simplify the medication process or alert the caregiver to potential dangers or inconsistencies. New capabilities such as onboard drug libraries, dose error reduction software and wireless connectivity that allow the pump to interface with patient EMRs and patient monitors are pushing infusion toward a new era where the complexities inherent in the drug infusion process can be automated and the associated risks reduced.
Infusion Medication Management Systems - What You Will Learn
- What infusion medication management systems are currently marketed or in development, who are the suppliers, and what are the specifics?
- What are the markets being targeted by infusion medication management systems?
- What are the essential features and capabilities of successful infusion medication management systems?
- What are the major factors that will are driving infusion medication management system demand?
- What is the addressable market for infusion systems?
- What is the expected impact of infusion medication management systems on infusion safety?
- Who are the significant players in this segment? What are their strategies? Who are their alliance partners?
Key Topics Covered:
1. Executive Summary
2. IV Administration Market Dynamics
- Evolution in Patient Care
- Demand Drivers
- Competitive Landscape
- Factors Limiting Growth
3. Infusion Pump Design Factors
- Automated Dose Calculation & Dose Error Reduction
- Connectivity Strategies
- Bar Codes and Bar Code Reading
- Wireless Communication
- Onboard Drug Libraries
- Flow Control and Dose Monitoring
- Software and Device Customization
- Alerts and Alarm Fatigue
4. Medication Management Feature Requirements
- Interoperability
- System Complexity and Caregiver Training
- Device Integration and Safety
- Technology Limitations and Risk Factors
5. Market Analysis
- Acute Care
- Ambulatory Surgery Centers
- Long-term Care
- Home Care
6. Sector Product Assessments
- Master Drug Libraries
- Electronic Bar Coding
- Location/Tracking
- Medication Preparation
- Dosing/Administration
- Data Sharing
- EMR/EHR Connectivity
7. Market Factors
- Regulatory Issues
- CyberSecurity
- Healthcare Economics
8. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/6btvwn/infusion
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables


OpenAI Addresses Security Vulnerability in macOS App Certification Process
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 



